Dare Bioscience Inc reports results for the quarter - Earnings Summary

Dare Bioscience

15/11/2024 14:04

* Dare Bioscience Inc  DARE.OQ  reported a quarterly
adjusted loss
of 55 cents​​ per share for the quarter , higher than the same
quarter last year, when the company reported EPS of $-1.08.  The
mean expectation of four analysts for the quarter was for a loss
of 73 cents per share. Wall Street expected results to range
from -93 cents to -61 cents per share.
    * Reported revenue was zero​; analysts expected $4.05
million. 
    * Dare Bioscience Inc's reported EPS for the quarter was a
loss
of 55 cents​.
    * The company reported a quarterly loss of $4.68 million.
    * Dare Bioscience Inc shares had risen by 10.0% this
quarter and
lost 3.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 4.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Dare Bioscience
Inc is 13.00 
This summary was machine generated from LSEG data November 15 at
02:04 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.73          -0.55          Beat
 Jun. 30 2024      0.00           -0.88          Missed
 Mar. 31 2024      -0.72          -0.84          Missed
 Dec. 31 2023      -1.18          -0.72          Beat